Display options
Share it on

Int J Mol Sci. 2014 May 07;15(5):7987-8003. doi: 10.3390/ijms15057987.

Endothelial nitric oxide synthase (eNOS) 4b/a gene polymorphisms and coronary artery disease: evidence from a meta-analysis.

International journal of molecular sciences

Yujiao Yang, Kang Du, Zhengxia Liu, Xiang Lu

Affiliations

  1. Department of Geriatrics, the Second Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China. [email protected].
  2. Department of Geriatrics, the Second Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China. [email protected].
  3. Department of Geriatrics, the Second Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China. [email protected].
  4. Department of Geriatrics, the Second Affiliated Hospital, Nanjing Medical University, Nanjing 210029, Jiangsu, China. [email protected].

PMID: 24810690 PMCID: PMC4057714 DOI: 10.3390/ijms15057987

Abstract

A variety of studies have suggested that the 4b/a polymorphism in the endothelial nitric oxide synthase (eNOS) was associated with coronary artery disease (CAD) risk. However, the data remain conflicting. The aim of the present meta-analysis was to estimate the overall association between risk of CAD and eNOS 4b/a polymorphism. Case-control, cohort or cross-sectional studies evaluating the association between eNOS 4b/a polymorphism and CAD susceptibility were systematically identified in PubMed up to 31 October 2013. Pooled odds ratios (OR) and corresponding 95% confidence intervals (CIs) were calculated to assess the association in overall and subgroup analyses. A total of 10,617 cases and 8302 controls from 37 studies were included in the study. The results of overall analysis revealed significant positive associations between CAD risk and eNOS 4b/a polymorphism in homozygote comparisons (OR = 1.47, 95% CI = 1.16-1.87), heterozygote comparisons (OR = 1.14, 95% CI = 1.02-1.27) and dominant models (OR = 1.18, 95% CI = 1.06-1.33). In subgroup analyses, similar associations were identified in African individuals, as determined using population-based source subgroups and noted in small-and-moderate sample size subgroups (case sample size or control sample size <500). The current meta-analysis revealed that eNOS 4b/a polymorphisms could be a risk factor for developing CAD, particularly in African populations and population-based subgroups.

References

  1. Hypertension. 1998 Sep;32(3):521-6 - PubMed
  2. Cardiology. 2010;116(4):271-8 - PubMed
  3. Biochem Genet. 2011 Feb;49(1-2):96-103 - PubMed
  4. Indian J Med Res. 2006 Dec;124(6):683-8 - PubMed
  5. Cytokine. 2013 Dec;64(3):646-51 - PubMed
  6. Acta Cardiol. 2008 Oct;63(5):609-14 - PubMed
  7. Atherosclerosis. 2012 Nov;225(1):1-10 - PubMed
  8. J Diabetes Complications. 2013 May-Jun;27(3):255-61 - PubMed
  9. J Thromb Thrombolysis. 1999 Oct;8(3):191-5 - PubMed
  10. Am Heart J. 2000 Oct;140(4):S27-35 - PubMed
  11. Atherosclerosis. 2000 May;150(1):179-85 - PubMed
  12. Control Clin Trials. 1986 Sep;7(3):177-88 - PubMed
  13. Lancet. 2012 Dec 15;380(9859):2129-43 - PubMed
  14. Heart Vessels. 2009 May;24(3):157-63 - PubMed
  15. Coron Artery Dis. 2006 Aug;17(5):413-7 - PubMed
  16. Heart. 2004 Mar;90(3):282-5 - PubMed
  17. Clin Chim Acta. 2010 Feb;411(3-4):258-62 - PubMed
  18. Clin Chem. 2000 Oct;46(10):1626-30 - PubMed
  19. Comp Biochem Physiol A Mol Integr Physiol. 2005 Oct;142(2):205-14 - PubMed
  20. Am J Cardiol. 1998 Jan 1;81(1):83-6 - PubMed
  21. Korean J Intern Med. 2000 Jan;15(1):65-70 - PubMed
  22. Nutr Res. 2012 May;32(5):342-6 - PubMed
  23. Exp Ther Med. 2010 Jul;1(4):719-724 - PubMed
  24. Exp Mol Pathol. 2010 Dec;89(3):205-8 - PubMed
  25. Circulation. 1996 Aug 1;94(3):266-71 - PubMed
  26. Cell. 1994 Sep 23;78(6):915-8 - PubMed
  27. Clin Chim Acta. 2007 Feb;377(1-2):154-62 - PubMed
  28. Ethn Dis. 2005 Spring;15(2):191-7 - PubMed
  29. Nitric Oxide. 2001 Aug;5(4):343-8 - PubMed
  30. J Biol Chem. 1993 Aug 15;268(23):17478-88 - PubMed
  31. Horm Metab Res. 2008 Jan;40(1):13-7 - PubMed
  32. Arch Med Res. 2012 Apr;43(3):205-11 - PubMed
  33. Chest. 1999 Oct;116(4):880-6 - PubMed
  34. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3321-5 - PubMed
  35. Atherosclerosis. 2002 Jan;160(1):167-75 - PubMed
  36. Cardiology. 2002;97(2):67-72 - PubMed
  37. Nat Med. 1996 Jan;2(1):41-5 - PubMed
  38. Saudi J Biol Sci. 2010 Jul;17(3):209-13 - PubMed
  39. Atherosclerosis. 2007 Jul;193(1):135-41 - PubMed
  40. Acta Cardiol. 2004 Dec;59(6):618-22 - PubMed
  41. J Cardiovasc Risk. 2001 Aug;8(4):235-41 - PubMed
  42. Clin Chim Acta. 2005 Apr;354(1-2):153-8 - PubMed
  43. Biochem Biophys Res Commun. 1998 Apr 7;245(1):190-3 - PubMed
  44. Int J Cardiol. 2014 Jan 1;170(3):309-14 - PubMed
  45. Vasc Med. 2001;6(2):103-8 - PubMed
  46. J Mol Med (Berl). 2000;78(7):372-9 - PubMed
  47. Circulation. 2004 Mar 23;109(11):1359-65 - PubMed
  48. Scand J Clin Lab Invest. 2000 May;60(3):229-35 - PubMed
  49. Diabetologia. 1998 Mar;41(3):365-6 - PubMed
  50. Folia Biol (Praha). 2005;51(2):47-9 - PubMed
  51. Clin Genet. 2002 Jan;61(1):66-70 - PubMed
  52. Am Heart J. 2004 Mar;147(3):516-21 - PubMed
  53. Clin Sci (Lond). 2004 Sep;107(3):255-61 - PubMed
  54. Cardiovasc Res. 1999 Aug 15;43(3):562-71 - PubMed
  55. Folia Biol (Praha). 2009;55(5):187-91 - PubMed
  56. Thromb Res. 2007;119(5):579-85 - PubMed
  57. Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):e1-4 - PubMed

Substances

MeSH terms

Publication Types